ELANCO ANIMAL HEALTH INC
ELANNYSE🏆 #818 by market capEarnings Nov 6US Equity
$22.61▲ $0.16 (+0.71%)
🌙 After hours$22.61▲ 0.00%Regular close · extended-hours price shownTrack ELAN
Get earnings, price moves & breaking news on Telegram
24h▲ 0.7%
7d▼ 1.4%
14d▼ 1.7%
30d▼ 6.3%
ytd▼ 0.1%
1y▲ 15.3%
🏦Market Cap
$11.29B
Mid Cap
📈Revenue Growth (YoY)
+6.2%
Slowing
📊Gross Margin
52.6%
Healthy
💵FCF Margin
7.5%
Moderate
⚖️P/S Ratio
2.2x
Cheap
Otter Score
68
Fair
ELANCO ANIMAL HEALTH INC
ELANAnalyst Ratings
Price
$22.61
Total
21
Raised
5
Lowered
1
Avg PT
$28.00
H / L
$30 / $26
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Buy | 2026-08-06 | $30.00 | +32.70% |
Keybanc | Reiterated | Overweight | 2026-08-06 | $30.00 | +32.70% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-22 | $26.00 | +15.00% |
TD Cowen | Reiterated | Buy | 2026-06-18 | — | — |
JP Morgan | Reiterated | Overweight | 2026-05-07 | $14.00 | −38.10% |
Citigroup | Reiterated | Buy | 2026-05-07 | $32.00 | +41.50% |
Leerink Partners | Reiterated | Outperform | 2026-02-24 | $30.00 | +32.70% |
Piper Sandler | Upgraded | Neutral → Overweight | 2026-01-22 | $30.00 | +32.70% |
Stifel | Reiterated | Buy | 2025-09-24 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2025-06-26 | — | — |
Barclays | Reiterated | Overweight | 2025-02-26 | $30.00 | +32.70% |
Goldman Sachs | Reiterated | Sell | 2024-02-27 | $32.00 | +41.50% |
Gabelli & Co. | Upgraded | Hold → Buy | 2021-05-11 | — | — |
Credit Suisse | Upgraded | Neutral → Outperform | 2021-02-26 | — | — |
Cleveland Research | Downgraded | Neutral → Underperform | 2020-07-27 | — | — |
B of A Securities | Reiterated | Buy | 2020-07-20 | — | — |
Raymond James | Reiterated | Market Perform → Perform | 2020-01-10 | — | — |
Bank of America | Upgraded | Neutral → Buy | 2019-12-19 | — | — |
Guggenheim | Reiterated | Neutral | 2019-05-23 | — | — |
BMO Capital | Reiterated | Market Perform | 2019-05-10 | — | — |
Argus | Reiterated | Buy | 2019-01-15 | — | — |
Institution
UBS
Reiterated · Buy · 2026-08-06
$30.00
+32.70%
Keybanc
Reiterated · Overweight · 2026-08-06
$30.00
+32.70%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-22
$26.00
+15.00%
TD Cowen
Reiterated · Buy · 2026-06-18
—
—
JP Morgan
Reiterated · Overweight · 2026-05-07
$14.00
−38.10%
Citigroup
Reiterated · Buy · 2026-05-07
$32.00
+41.50%
Leerink Partners
Reiterated · Outperform · 2026-02-24
$30.00
+32.70%
Piper Sandler
Upgraded · Neutral → Overweight · 2026-01-22
$30.00
+32.70%
Stifel
Reiterated · Buy · 2025-09-24
—
—
William Blair
Upgraded · Market Perform → Outperform · 2025-06-26
—
—
Barclays
Reiterated · Overweight · 2025-02-26
$30.00
+32.70%
Goldman Sachs
Reiterated · Sell · 2024-02-27
$32.00
+41.50%
Gabelli & Co.
Upgraded · Hold → Buy · 2021-05-11
—
—
Credit Suisse
Upgraded · Neutral → Outperform · 2021-02-26
—
—
Cleveland Research
Downgraded · Neutral → Underperform · 2020-07-27
—
—
B of A Securities
Reiterated · Buy · 2020-07-20
—
—
Raymond James
Reiterated · Market Perform → Perform · 2020-01-10
—
—
Bank of America
Upgraded · Neutral → Buy · 2019-12-19
—
—
Guggenheim
Reiterated · Neutral · 2019-05-23
—
—
BMO Capital
Reiterated · Market Perform · 2019-05-10
—
—
Argus
Reiterated · Buy · 2019-01-15
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space